Bristol Projects Opdivo Sales Will Grow Again In 2021

SC1910_Lung Cancer_47781766_1200.jpg
Bristol expects first-line lung cancer to boost Opdivo sales starting in 2021. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Business